COMMUNIQUÉS West-GlobeNewswire

Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024

23/05/2024 - 08:00

GUANGZHOU, China, May 23, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) [...]

ONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights

23/05/2024 - 07:30

Nature Medicine published Up-LIFT pivotal trial results Submitted FDA De Novo application for ARC-EX ® System Successfully raised EUR 20M in equity capital EINDHOVEN, the Netherlands, May 23, 2024 (GLOBE NEWSWIRE) -- [...]

EUROAPI strengthens its presence in animal health with a €130-150 million supply contract

23/05/2024 - 07:00

Press Release A 5-year manufacturing contract to support the FOCUS-27 project sales trajectory This contract highlights EUROAPI’s know-how and the reliability of its premium Contract Manufacturing Organization services [...]

EUROAPI renforce sa présence en santé animale avec un contrat de fourniture de 130-150 millions d’euros

23/05/2024 - 07:00

Communiqué de presse Un contrat de fabrication de 5 ans qui soutiendra la trajectoire de ventes du projet FOCUS-27 Ce contrat souligne le savoir-faire d’EUROAPI et la fiabilité des services premium de Contract [...]

Vivoryon Therapeutics N.V. Reports Q1 2024 Financial Results and New Data Reinforcing Strategic Focus in Kidney Disease

23/05/2024 - 07:00

Vivoryon Therapeutics N.V. Reports Q1 2024 Financial Results and New Data Reinforcing Strategic Focus in Kidney Disease Additional kidney function analyses strongly support Vivoryon’s shift in strategic focus to [...]

Idorsia issues invitation to the 2024 Annual General Meeting of Shareholders

23/05/2024 - 07:00

Allschwil, Switzerland – May 23, 2024 Idorsia Ltd (SIX: IDIA) today issued the invitation to the upcoming Annual General Meeting (AGM) of Shareholders on behalf of the Board of Directors. The meeting to approve the [...]

IBA Business Update – First Quarter 2024

23/05/2024 - 07:00

Louvain-la-Neuve, Belgium, 23 May 2024 - IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, today announces its business update for the first quarter ending 31 March 2024. Group [...]

IBA déclaration intermédiaire - Premier trimestre 2024

23/05/2024 - 07:00

Louvain-la-Neuve, Belgique, le 23 mai 2024 - IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d’accélération de particules, publie aujourd'hui la revue de ses activités pour le premier [...]

Cytokinetics Announces Pricing of Public Offering of Common Stock

23/05/2024 - 05:30

SOUTH SAN FRANCISCO, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the pricing of an underwritten public offering of 9,803,922 shares of its common stock at a price [...]

Foghorn Therapeutics Raises Approximately $110 Million Through Registered Direct Offering to Advance Pipeline

23/05/2024 - 00:21

Positions company to further leverage strength of platform and advance programs through multiple data readouts and clinical value inflection points Strengthens balance sheet with cash, cash equivalents and short-term [...]

Progyny, Inc. Announces Additional Share Repurchase Program

22/05/2024 - 23:00

NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, announced today that its Board of Directors has approved a [...]

Adagene to Present at Investor Conferences in June

22/05/2024 - 22:45

SAN DIEGO and SUZHOU, China, May 22, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced its [...]

Kronos Bio to Participate in Three Upcoming Healthcare Conferences and Events

22/05/2024 - 22:30

SAN MATEO, Calif. and CAMBRIDGE, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to developing small molecule therapeutics that address cancers and other diseases driven by [...]

Codexis to Participate in Jefferies Global Healthcare Conference

22/05/2024 - 22:25

REDWOOD CITY, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will attend the Jefferies Global Healthcare Conference, being held [...]

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

22/05/2024 - 22:16

CHASKA, Minn., May 22, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization, today announced that [...]

Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

22/05/2024 - 22:15

GAITHERSBURG, Md., May 22, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer [...]

Nyxoah Announces Reduction of the Maximum Amount Available Under its At the-Market Equity Offering Program

22/05/2024 - 22:10

REGULATED INFORMATION INSIDE INFORMATION Nyxoah Announces Reduction of the Maximum Amount Available Under its At-the-Market Equity Offering Program Mont-Saint-Guibert, Belgium – May 22, 2024, 10:10pm CET / 4:10pm ET – [...]

Nyxoah Annonce une Réduction du Montant Maximum Disponible dans le Cadre de son Programme d'Offre d'Actions At-the-Market

22/05/2024 - 22:10

INFORMATIONS PRIVILÉGIÉES INFORMATIONS RÉGLEMENTÉES Nyxoah Annonce une Réduction du Montant Maximum Disponible dans le Cadre de son Programme d'Offre d'Actions At-the-Market Mont-Saint-Guibert, Belgique – 22 mai 2024, [...]

Dentsply Sirona Declares Quarterly Cash Dividend

22/05/2024 - 22:10

CHARLOTTE, N.C., May 22, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.16 per share of [...]